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The data here consists of time-dependent experimental parameters
from chemical and biophysical methods used to characterize Aβ
monomeric reactants as well as soluble oligomer and amyloid ﬁbril
products from a slow (3–4week) assembly reaction under biologically-
relevant solvent conditions. The data of this reaction are both of a
qualitative and quantitative nature, including gel images from chemical
cross-linking and Western blots, fractional solubility, thioﬂavin T
binding, size exclusion chromatograms, transmission electron micro-
scopy images, circular dichroism spectra, and ﬂuorescence resonance
energy transfer efﬁciencies of donor–acceptor pair labels in the Aβ
chain. This data enables future efforts to produce the initial monomer
and eventual soluble oligomer and amyloid ﬁbril states by providing
reference benchmarks of these states pertaining to physical properties
(solubility), ligand-binding (thioﬂavin T binding), mesoscopic structure
(electron microscopy, size exclusion chromatography, cross-linking
products, SDS and native gels) and molecular structure (circularier Inc. This is an open access article under the CC BY license
/j.ab.2015.03.032
Finke).
y, University of Michigan, Ann Arbor MI, United States.
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Aβ1-40 soluble oligomers are produced that are suitable for
biophysical studies requiring sufﬁcient transient stability to exist in
their “native” conformation in biological phosphate-saline buffers for
extended periods of time. The production involves an initial prepara-
tion of highly monomeric Aβ in a phosphate saline buffer that
transitions to ﬁbrils and oligomers through time incubation alone,
without added detergents or non-aqueous chemicals. This criteria
ensures that the only difference between initial monomeric Aβ
reactant and subsequent Aβ oligomer products is their degree of
peptide assembly. A number of chemical and biophysical methods
were used to characterize the monomeric reactants and soluble
oligomer and amyloid ﬁbril products, including chemical cross-linking,
Western blots, fraction solubility, thioﬂvain T binding, size exclusion
chromatography, transmission electron micrscopy, circular dichroism
spectroscopy, and ﬂuorescence resonance energy transfer.
& 2015 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations TableSubject area Biochemistry
More speciﬁc
subject areaAnalytical BiochemistryType of data Text ﬁle and ﬁgures
How data was
acquiredSize-exclusion chromatography (SEC): Sephacryl S-200HR column (GE Life Sciences) with a
Pharmacia peristaltic pump and Gilson Fraction collector. Gel imaging: Odyssey Infrared Imaging
System (LI-COR Biosciences, Lincoln, NE), Gel Logic 100 Digital Imaging System (Kodak) using a Dark
Reader Transilluminator (Clare Chemical). Absorbance: Cary 100 spectrophotometer (Cary). Steady-
state ﬂuorescence: PTI Quanta Master Steady-State ﬂuorimeter (Photon Techonologies Inc). Time-
resolved ﬂuorescence: PTI EasyLife equipped with a 295 nm LED excitation source and 395 cut-on
emission ﬁlter. CD spectra: Chirascan spectropolarimeter (Applied Photophysics). Electron
microscopy: Morgagni 268 Transmission Electron Microscope (TEM) equipped with a Hamamatsu
digital camera.Data format Analyzed
Experimental factors All samples were measured either directly or with preparation steps essential to the actual
experiment. Speciﬁcally (1) PICUP experiments involved raw sample treatment with cross-linking
agent Tris(2,20-bipyridyl)dichlororuthenium(II); (2) Thioﬂavin T ﬂuorescence was measured after
raw sample dilution into 25 mM ThT; (3) Samples for electron microscopy are ﬁxed with
glutaraldehyde and dried on a formar grid.Experimental
featuresSize exclusion chromatographyData source location Tacoma, Pierce County, Washington State, USA
Data accessibility Data is with this article.1. Value of the data(1) The data provides descriptive experimental biophysical parameters obtained on a speciﬁc
preparation method of Aβ monomers, soluble oligomers, and insoluble aggregates.(2) The preparation method described is used to facilitate a slow Aβ assembly process under
biologically-consistent solvent conditions that also enable extensive study of initial monomers
during the ﬁrst 2–3 days and a stable oligomer/aggregate equilibrium at longer times.
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(PICU
undeThe data provides a means by which future Aβ oligomer preparations can conﬁrm a similar
oligomer macroscopic and molecular structure as that used in the present article2. Data, experimental design, materials and methods
The data of the present article provides a biochemical and biophysical parameters that characterize
Aβ soluble oligomers produced through a speciﬁc protocol and also measured a various time points
during the oligomer incubation. The data included are from experiments of Photo-Induced Cross-
Linking of Proteins (PICUP), Fraction Soluble Protein, Thioﬂavin T (ThT) binding, Size Exclusion
Chromatographic (SEC) data, Transmission Electron Microscopy (TEM) images, Western Blot images,
Circular Dichroism (CD) spectroscopy spectra, and ﬂuorescence resonance energy transfer (FRET)
efﬁciencies. There experiments were performed to characterize the time stages during the monomer-
to-oligomer transition and subsequent oligomer isolation from the ﬁnal oligomer/ﬁbril product
mixture.
This data is important as a wide variation of Aβ soluble oligomer forms have been shown to result
from different preparation conditions [1]. Thus, the value of the data is to facilitate future scientiﬁc
efforts that require replication of this particular oligomer species. The data here pertain to a speciﬁc
form of “native” oligomers (nOAβ) whose production follows the following criteria: (1) the nOAβ
preparation initially starts with highly pure MAβ in499% molar excess phosphate-saline buffer and
(2) nOAβ must be generated from this initial MAβ preparation by time alone (no change in solution
conditions or seeding). These criteria were selected to ensure that the only difference between
preparations corresponding to the initial Aβ monomers (MAβ) and subsequently formed nOAβ
oligomers is the degree of peptide assembly. Solvent conditions remain constant and oligomer
formation is driven by inherent kinetic mechanisms from the monomer state without inﬂuence of
amyloid “seeds”.3. Data
A highly pure initial MAβ preparation is a criteria for the production of nOAβ. Fig. 1 conﬁrms this
initial state with SDS-PAGE Western blots performed on PICUP experiments with t¼0, 1, and 30 s of
light exposure. The gel in Fig. 1 conﬁrms the expected results of a single band at the expected1. Aβ monomer preparations are of high purity. SDS-PAGE analysis of Photoinduced Cross-Linking of Unmodiﬁed Proteins
P) treatment of freshly prepared monomeric Aβ (MAβ). The time of light exposure (in seconds) during PICUP is shown
r each gel lane.
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ladder of oligomer bands in the positive control (30 s lane). The integrated signal of oligomers in the
30 s lane was approximately equal to the 0 sec PICUP lane indicating that no larger insoluble
aggregates had formed at exposure times less than 30 sec. Also, the oligomer distribution from
infrared ﬂuorescence is consistent with that of the 30 s exposure of Aβ1–40 in the original PICUP study
[2]. The PICUP experiment here used 1 s of light exposure and retained monomer band as the highest
intensity band but also produced 2–5 fainter higher-order bands that decreased in intensity at greater
size. Compared with previous PICUP results, this ﬁnding is consistent with a monomeric Aβ sample
because low amounts of 2–5mer bands are expected to result from diffusional collisions of monomeric
polypeptides [2].
Analyses of the transition of the initial MAβ preparation into nOAβ and ﬁbrillar Aβ (FAβ) over time
are shown in Fig. 2. Fig. 2a shows that the Aβ Fraction Soluble decreases to 0.3 after 40 days, indicating
the increasing population of insoluble aggregates. This decrease in Fraction Soluble occurred alongFig. 2. Aβ oligomer production and puriﬁcation from an initial Aβ monomer preparation. (a) Fraction Soluble Aβ (▬●▬) and
Thioﬂavin T binding ( ) of the monomer-to-oligomer incubation every ten days. Thioﬂavin T binding was also
measured for centrifuged aliquots of the oligomer incubation ( ). (b) Size exclusion chromatography of 1 ml
aliquots from the monomer-to-oligomer incubation run on Day 0 (▬▬▬), Day 21 (————————), and on Day 42 ( ∙∙∙∙∙∙∙∙∙∙∙∙∙∙∙ ).
Also shown are control SEC measurements of ﬂuorescent 10 μM aminobenzamide doped into the monomer-to-oligomer
incubation on Day 0 ( ) and on Day 42 ( ). Arrows indicate the void volume Vo, total volume Vt, and elution
peaks associated with monomeric MAβ and oligomeric nOAβ. (c) A transmission electron microscopy image of ﬁbrils and
oligomers after 42 days of incubation. (d) A transmission electron microscopy image of nOAβ puriﬁed by SEC.
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further conﬁrmed by the absence of enhanced ThT ﬂuorescence in centrifuged samples, demonstrat-
ing that ThT ﬂuorescence could not be attributed to nOAβ.
Fig. 2b shows the results of SEC on the nOAβ incubation at 0, 21, and 42 days. On Day 0, the
incubation is entirely MAβ (Kav0.6, fraction 28) but transitions to two early-eluting nOAβ peaks by
Day 42 (Kav0.35/fraction 22 and Kav0.5/fraction 25) [3]. The fraction of soluble Aβ recovery (0.21)
from SEC integrated peak areas on Day 42 was comparable to the Fraction Soluble (0.3) in Fig. 2a. The
largest peak in fraction 22, containing 0.15 of initial Aβ, was collected as the ﬁnal product for
biophysical studies and TEM analysis. To test any change in column performance with injected MAβ
and nOAβ solutions, 10 mM of o-aminobenzamide (ABZ) was added to the Aβ incubations on Day 0
(MAβ) and Day 42 (nOAβ) and injected on the SEC column. The ABZ elution volume was used to assess
changes in Vt in these two preparations. While some peak broadening was observed on Day 42, no
change in the elution volume was observed.
TEM of the raw Aβ incubation on Day 42 shows that a signiﬁcant level of FAβ along with spherical
structures on or near the ﬁbrils (Fig. 2c). Similar spherical structures are also observed in TEM scans of the
SEC puriﬁed nOAβ (Fig. 2d). These TEM studies indicate that nOAβ co-populates with FAβ but is of sufﬁcient
stability to enable puriﬁcation by SEC.
Analysis of the Aβ incubation on Day 0 by both native (Fig. 3a) and SDS-PAGE (Fig. 3b) Western
Blots shows a single band consistent with the highly pure MAβ solution determined by PICUP (Fig. 1).
On Day 42, native Western Blots show that the MAβ band is gone and replaced with a single large
nOAβ band near the top of the gel (Fig. 3a). Under SDS-PAGE conditions, this nOAβ band partially
denatures into sOAβ fragments (Fig. 3b).
A structural analysis of these Aβ states by CD (Fig. 3c) shows random coil MAβ conformations on
Day 0 (gray spectrum A) with increased β-sheet structure on Day 42 when nOAβ and FAβ predominate
(black spectrum B) [4]. Centrifugation of the Day 42 sample removes FAβ and other insoluble
aggregates, leaving only nOAβ (dotted spectrum C). Subtraction of centrifuged from uncentrifuged Day
42 spectra reveals a spectra consistent with β-sheet conformations for FAβ (dashed spectrum D) [4].
Using the wavelength of minimum ellipticity (λminθ) as a reaction coordinate for the structural
transition between the MAβ coil (λminθ of A¼201 nm) and the FAβ β-sheet (λminθ of D¼216 nm), the
nOAβ spectra (λminθ of C¼203 nm) is more similar to MAβ.
An extended longitudinal analysis of nOAβ polypeptide conformational stability was performed
using the FRET efﬁciency E between a ﬂuorescent donor at position 35 and acceptor at position 10
(Fig. 3d). A rapid decrease in FRET efﬁciency occurs in the ﬁrst 40 days of incubation as the soluble
fraction transitions from MAβ (E¼0.21) into nOAβ. (E¼0.15). After soluble nOAβ has equilibrated
with insoluble FAβ at 40 days, further incubation produces only minimal change after 11 months
(E¼0.12). While the results of Fig. 3d cannot rule out changes in the quarternary assembly states of
nOAβ, the average molecular conformation of the constituent nOAβ peptides remains stable for at
least one year.4. Materials and methods
4.1. Instrumentation
Size-exclusion chromatography (SEC) was performed with a Sephacryl S-200HR column (GE Life
Sciences) with a Pharmacia peristaltic pump and Gilson Fraction collector. Absorbance spectra were
acquired on a Cary 100 spectrophotometer (Cary). Steady-state ﬂuorescence measurements were
acquired on a PTI Quanta Master Steady-State ﬂuorimeter (Photon Techonologies Inc). Time-resolved
ﬂuorescence measurements were acquired on a PTI EasyLife equipped with a 295 nm LED excitation
source and 395 cut-on emission ﬁlter. CD measurements were acquired on a Chirascan spectro-
polarimeter (Applied Photophysics). Electron microscopy was performed using a Morgagni 268
Transmission Electron Microscope (TEM) equipped with a Hamamatsu digital camera.
Fig. 3. Structural analysis of oligomeric Aβ. (a) Native and (b) SDS-PAGE Western blots were imaged on Day 0 and on Day 42 of
the Aβ monomer-to-oligomer incubation. (c) Uncorrected circular dichroism spectra were acquired on the Aβ monomer-to-
oligomer incubation on Day 0 (A, ), Day 42 (B, ▬▬▬), and Day 42 after centrifugation (C, ∙∙∙∙∙∙∙∙∙∙∙∙∙∙∙). A subtracted
spectra of B-C shows an estimated spectrum of insoluble Aβ on Day 42 (D, ————————). (d) FRET efﬁciency E between the
aminobenzamide donor at residue 35 and nitrotyrosine acceptor at position 10 of FRET –labeled Aβ peptides in soluble states
(MAβ and nOAβ) over the course of 365 days. The FRET-labeled Aβ was 2 μM (4%) of the total 50 μM Aβ sample, a dilution
sufﬁcient to observe only intramolecular FRET and no intermolecular FRET.
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All Aβ preparations involved initial production of monomeric Aβ (MAβ) with a slightly modiﬁed
published protocol [5]. Commerical Aβ1–40 (Anaspec, San Jose) was dissolved in a 50:50 triﬂuoroacetic
acid (TFA):hexaﬂuoroisopropanol (HFIP) at a 1 mg/ml, sonicated for 1 h at room temperature,
evaporated into a dry ﬁlm under Argon gas, resuspended at 0.5 mg/ml peptide (114 μM) in aqueous
TFA pH 3, microcentrifuged at 14,000 g for 10 min, and ﬁltered through a 10,000 MWCO Amicon
ﬁlter. The molar concentration of this MAβ stock solution was determined from UV spectroscopy using
ε280¼1280 M1 cm1 of Tyr10 [6]. For experiments, the MAβ stock was brought to 50 μMMAβ,
100 mM phosphate, 100 mM NaCl, 0.00075 M TFA, pH 7.4. For experimental analysis of MAβ or
immobilization of MAβ for SPR, the MAβ stock was stored at 4 1C and used within 3 days of
disaggregation.
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and this mature OAβ preparation used within 6 months. Prior to experimental analysis or SPR
immobilization, OAβwas initially isolated from FAβ using 12,000 g centrifugation. OAβ in the supernatant
was further puriﬁed using size-exclusion chromatography (SEC) calibrated with dextran blue (2000 kD),
cytochrome c (13 kD), and sodium chromate (0.162 kD). SEC was conducted at 1 ml/min and eluting Aβ
species were identiﬁed with intrinsic Tyr10 ﬂuorescence (ex 280 nm, em 340 nm). The dominant OAβ peak
was identiﬁed at approximately Kav¼0.35 and collected. OAβ puriﬁed in this manner was used for
experiments or SPR immobilization within 1 week of elution from the column.
4.3. PICUP experiments
To conﬁrm the absence of any minor OAβ and FAβ components in the initial preparation, Photo-
Induced Cross-Linking of Unmodiﬁed Proteins (PICUP) was used [2]. A 40 μl solution of 1 μM
ammonium persulfate, 50 μM Tris(2,20-bipyridyl)dichlororuthenium(II), and 45 μM Aβ solution was
prepared in the dark. The solution was then exposed to a 250 W tungsten lamp (GE) for 1 s in the
chamber of a DS34 Polaroid Camera (F-stop set to 4.5). In the dark, crosslinking in the sample was
quenched with the addition of 10 uL of 100 mM Tricine with 5% BME. A negative control was
performed with no light exposure and positive control was performed with 30 s of light exposure.
Samples were run on SDS-PAGE Western Blots.
4.4. Western blots
Both SDS and native gels used 4–20% Tris–HCl Ready Gels (Bio-Rad). For SDS-PAGE gels, Aβ samples
were mixed 1:1 with Laemmli Sample Buffer (Bio-Rad) without heating and electrophoresis
performed with Tris-Glycine-SDS (0.1% SDS) running buffer (BioRad). For native gels, Aβ samples
were mixed 1:2 with Native Sample Buffer (BioRad) without heating and electrophoresis performed
with Tris-Glycine buffer (BioRad). After electrophoresis, transfer to Westran S PVDF membranes
(Whatman) was performed using a MiniProtean II (BioRad) or iBlot system (Invitrogen).
For PICUP experiments, immunoblotting was performed using near infrared ﬂuorescence imaging
as follows. The membrane was blocked with a Near Infrared Fluorescent Blocking Buffer (Rockland
Immunocytochemicals, Gilbertsville, PA) for 1 h at room temperature, incubated with mAb 6E10
(1:5000 dilution) overnight at 4 1C, and in Mouse IgG IRDye800 Conjugated Rabbit Polyclonal solution
(Rockland Immunocytochemicals; 1:15,000 dilution) for 1 h at room temperature. Infrared image was
performed with the Odyssey Infrared Imaging System (LI-COR Biosciences, Lincoln, NE).
For non-PICUP Western Blots, immunoblotting with 6E10 and chemiluminescent imaging were
performed as described in previous work [7]. Brieﬂy, this process involved 1 h of blocking in 10% non-fat
dry milk in phosphate buffered saline, overnight incubation with a 1:5000 dilution of 1 mg/ml 6E10
primary antibody (Covance) at 4 1C, and a one hour incubation with a 1:10,000 dilution of horseradish
peroxidase conjugated goat anti-mouse IgG1 secondary antibody (Vector Labs). Membranes were
developed in SuperSignal West Pico chemiluminescent substrate and bands detected on CL-XPosure ﬁlm
(Thermo Scientiﬁc). Immunoblotting for SDS-PAGE shown in the present work was performed using the
visible-ﬂuorescence method of the goat-antimouse Western Dot 625 Kit (Invitrogen W10132). The
procedure followed the instructions in the kit and used a 1:1000 dilution of 1 mg/ml 6E10 primary
antibody and 1:1000 dilution of goat anti-mouse IgG1 secondary antibody. Imaging was performed with a
Gel Logic 100 Digital Imaging System (Kodak) using a Dark Reader Transilluminator (Clare Chemical).
4.5. Aggregation assays
Conversion of soluble Aβ species into insoluble aggregates was assessed in the Aβ incubation
through measurement of Fraction Soluble, calculated using Eq. (1) [3]
Fraction Soluble¼ A
t ¼ n
280
At ¼ 0280
ð1Þ
A.C. Crisostomo et al. / Data in Brief 4 (2015) 650–658 657In Eq. (1), At ¼ 0280 is the 280 nm absorbance on Day 0 and A
t ¼ n
280 is the 280 nm absorbance on Day “n”,
measured after centrifugation at 12,000 g. The experiment was run in quadruplet (n¼4).
During the time course of the OAβ incubation, Thioﬂavin T (ThT) binding was determined in the
raw preparation and also in a centrifuged portion of the preparation. Although not entirely speciﬁc,
ThT binds amyloid ﬁbrils quantitatively and produces an increase in ﬂuorescence yield proportional to
the extent of peptides in the amyloid state [3,8,9]. While ThT binding does not provide a direct
measurement of amyloid ﬁbril concentration, it is an accurate gauge of the fraction of amyloid ﬁbrils
formed in a preparation solution at a given time versus that present earlier or later. In the present
study, a 40 μl aliquot of each Aβ sample was added to 1 ml of 25 μM ThT (100 mM sodium phosphate,
100 mM NaCl, pH 7.4) and incubated for 30 min [3]. ThT binding was quantiﬁed using Eq. (2)
ThT Binding¼
ITþS  IBþ S
ITþB  IB 1 ð2Þ
In Eq. (2), ITþS is the ﬂuorescence (excitation 450 nm, emission 480 nm) of ThT with Aβ sample
added, IBþS is a ﬂuorescence correction for residual light scattering consisting of 40 μl Aβ sample in
1 mL buffer, ITþB is the intrinsic ﬂuorescence of the 1 ml ThT solution with 40 μL of buffer added, and
IB is the buffer background. The experiment was run in quadruplet (n¼4).
4.6. Electron microscopy
A 70 μL sample aliquot was incubated on a formar grid for 20 min, ﬁxed with 1 added drop of 1%
glutaraldehyde in 100 mM phosphate buffer and 10 min incubation, rinsed in distilled water, stained
with 1% uranyl acetate for 10 min, rinsed again and dried. Approximately 10 scans within the ﬁeld
were collected for each sample.
4.7. Circular dichroism
CD spectra were acquired for 0.5 s every 1 nm over a wavelength range of 195–260 nm with
sample in a quartz cuvette with a 0.1 cm pathlength. The CD spectra presented are the average of ﬁve
such spectra collected in series.
4.8. Fluorescence resonance energy transfer (FRET) studies
FRET analysis of peptide conformation in soluble oligomers followed a published methodology [3].
For FRET studies, two samples were prepared and incubated as described inMonomeric and Oligomeric
Aβ Preparation with 48 μM unlabeled Aβ plus 2 μM of one of two ﬂuorescent-labeled Aβ peptides: (1)
D-Aβ or (2) D-Aβ-A. In these peptides, D indicates a substitution of (o-aminobenzoyl)lysine for
methionine at position 35 (ﬂuorescence energy donor, EXmax¼320 nm, EMmax¼420 nm) and A
indicates a substitution of o-nitrotyrosine for tyrosine at position 10 (nonﬂuorescent FRET acceptor).
On each day of analysis (Day 0, 21, 42, and 365), two aliquots from both D-Aβ and D-Aβ-A
preparations were removed. One aliquot was measured directly and the second was micro-
centrifuged at 12,000 rpm prior to analysis to remove insoluble aggregates. To track reaction progress
and conﬁrm consistency with the unlabeled Aβ oligomer incubation, both aliquots were analyzed with
steady-state ﬂuorescence, ﬂorescence anisotropy, light scattering, turbidity, and thioﬂavin T binding
(not shown).
The primary determination of FRET efﬁciency was performed using the time resolved ﬂuorescence
decay lifetimes of D-Aβ and D-Aβ-A samples. After deconvolution with the instrument response
function using Savuka software, the time-dependent ﬂuorescence decay A(t) of soluble D-Aβ and D-
Aβ-A peptides was well characterized using the single exponential ﬁtting model shown in Eq. (3) [10]
AðtÞ ¼ Axe
t
τxþAð1Þ ð3Þ
Eq. (3) shows the ﬁtted ﬂuorescence lifetime τx, signal amplitude Ax, and ﬁnal signal value A(1) of
the ﬂuorescence decay corresponding to either X¼D-Aβ or X¼D-Aβ-A [10]. The time resolved
A.C. Crisostomo et al. / Data in Brief 4 (2015) 650–658658ﬂuorescence decay lifetimes τD-Aβ and τD-Aβ-A were used to determine the FRET efﬁciency (E) as shown
in Eq. (4) [11,12]
E¼ 1 τDAβA
τDAβ
ð4Þ
Between values of 0.1–0.9, E is roughly proportional to the average D-A distance in the sample. The
1:24 ratio of labeled D-Aβ-A versus unlabeled Aβ used here was shown to suppress all intermolecular
FRET between neighboring DA peptides in a prior study of polyglutamic acid [3]. Thus, E here provides
a probe of Aβ molecular conformation reﬂected in the intramolecular D-A distance of D-Aβ-A.Acknowledgments
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